ClinConnect ClinConnect Logo
Search / Trial NCT06570785

IOPS Technology During Cannnulation of Contralateral Limb in EVAR

Launched by CLINICAL CENTRE OF SERBIA · Aug 22, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Abdominal Aortic Aneurysm Endo Vascular Aneurysm Repair Radiation Protection

ClinConnect Summary

This clinical trial is studying a new technology called the Intra-Operative Positioning System (IOPS) to see how it can help reduce radiation exposure during a procedure called EndoVascular Aneurysm Repair (EVAR). EVAR is a minimally invasive surgery used to treat abdominal aortic aneurysms (AAA), which are bulges in the main artery that can be dangerous if they rupture. The IOPS technology allows doctors to navigate and visualize the devices used in this procedure in 3D, which could make the surgery safer for patients and healthcare providers by reducing their exposure to harmful radiation.

To participate in this study, you need to be an adult over 18 years old with a specific type of AAA that is not ruptured or symptomatic. Unfortunately, those who are pregnant, younger than 40, have more complicated types of aneurysms, or are undergoing open surgery or more advanced treatments won't be eligible. If you join the trial, you can expect to have the standard EVAR procedure with the added benefit of this new technology, which aims to improve safety and precision during surgery. This study is set to start between September 2024 and May 2025, and it's an important step toward making these life-saving procedures even safer for everyone involved.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - All patients (over 18 years of age) with infrarenal AAA treated between 1st September 2024 and 1st May 2025 undergoing standard EVAR according to the IFU
  • Exclusion Criteria:
  • Patients who are pregnant
  • Patients who are under 40 years of age
  • Patients who have symptomatic or ruptured AAA
  • Patients with more advanced AAA: juxtarenal, pararenal, suprarenal, thoracic, thoracoabdominal AAA
  • Non-atherosclerotic origin of disease: dissection, connective tissue disorders, mycotic AAA, posttraumatic AAA
  • Patients who were treated in a conservative manner
  • Patients undergoing open surgery
  • Patients undergoing more advanced treatment options: fenestrated/branched EVAR, endostaplers, chimney EVAR, iliac branch devices, etc.

About Clinical Centre Of Serbia

The Clinical Centre of Serbia is a leading healthcare institution dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor of clinical studies, the Centre emphasizes rigorous scientific methodology and ethical standards, fostering collaborations with local and international research organizations. With a multidisciplinary team of experienced researchers and clinicians, the Clinical Centre of Serbia aims to contribute to the development of new therapeutic interventions and enhance clinical practices, ultimately benefiting patient populations in Serbia and beyond.

Locations

Belgrade, , Serbia

Patients applied

0 patients applied

Trial Officials

Igor Koncar, MD PhD

Study Chair

University Clinical Centre of Serbia

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported